Skip to content

Effects of Lactobacillus paracasei N1115 on serum lipids: human intervention study

Effects of Lactobacillus paracasei N1115 on serum lipids: human intervention study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IIR-17013099
Enrollment
Unknown
Registered
2017-10-24
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia

Interventions

Intervention group:Oral intake probiotics, Lactobacillus paracasei N1115
Control group:Oral intake placebo

Sponsors

Peking University Health Science Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 35~65 years old, total cholesterol=5.18 mmol/L(or 200mg/dL) and <6.99 mmol/L(270mg/dL);Inclusion criteria: Aged 35~65 years old, total cholesterol=5.18 mmol/L(or 200mg/dL) and <6.99 mmol/L(270mg/dL);Inclusion criteria: Aged 35~65 years old, total cholesterol=5.18 mmol/L(or 200mg/dL) and <6.99 mmol/L(270mg/dL);Inclusion criteria: Aged 35~65 years old, total cholesterol=5.18 mmol/L(or 200mg/dL) and <6.99 mmol/L(270mg/dL);Inclusion criteria: Aged 35~65 years old, total cholesterol=5.18 mmol/L(or 200mg/dL) and <6.99 mmol/L(270mg/dL)

Exclusion criteria

Exclusion criteria: Inability to complete study, lactose intolerance, allergic to cow milk, severe digestive system disease, pregnant or nursing women, severe heart or brain disease, diabetes, hepatic disease, renal disease, any disease in blood system, cancer, mental disorders, memory problems and use of hypolipidemic drugs or other functional food.;Exclusion criteria: Inability to complete study, lactose intolerance, allergic to cow milk, severe digestive system disease, pregnant or nursing women, severe heart or brain disease, diabetes, hepatic disease, renal disease, any disease in blood system, cancer, mental disorders, memory problems and use of hypolipidemic drugs or other functional food.;Exclusion criteria: Inability to complete study, lactose intolerance, allergic to cow milk, severe digestive system disease, pregnant or nursing women, severe heart or brain disease, diabetes, hepatic disease, renal disease, any disease in blood system, cancer, mental disorders, memory problems and use of hypolipidemic drugs or other functional food.;Exclusion criteria: Inability to complete study, lactose intolerance, allergic to cow milk, severe digestive system disease, pregnant or nursing women, severe heart or brain disease, diabetes, hepatic disease, renal disease, any disease in blood system, cancer, mental disorders, memory problems and use of hypolipidemic drugs or other functional food.;Exclusion criteria: Inability to complete study, lactose intolerance, allergic to cow milk, severe digestive system disease, pregnant or nursing women, severe heart or brain disease, diabetes, hepatic disease, renal disease, any disease in blood system, cancer, mental disorders, memory problems and use of hypolipidemic drugs or other functional food.

Design outcomes

Primary

MeasureTime frame
Total cholesterol;Triglyceride;low density lipoprotein cholesterin;high density lipoprotein cholesterin;Apo-A;Apo-B;

Secondary

MeasureTime frame
Body weight;waistline;hipline;body fat percentage;Gut microbiota;

Countries

China

Contacts

Public ContactYumei Zhang;Yumei Zhang;Yumei Zhang;Yumei Zhang;Yumei Zhang ;;;;

Peking University;Peking University;Peking University;Peking University;Peking University

zhangyumei@bjmu.edu.cn;zhangyumei@bjmu.edu.cn;zhangyumei@bjmu.edu.cn;zhangyumei@bjmu.edu.cn;zhangyumei@bjmu.edu.cn+86 13426134251;+86 13426134251;+86 13426134251;+86 13426134251;+86 13426134251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026